Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$28.29+0.02 (+0.07%)
Close on Nov 18, 2026Market cap $1.69BP/E –Yield –
Kestra Medical Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Kestra Medical Technologies's revenue for the twelve months ending Jul 31, 2026 was $106.73M, up 60.7% year over year. For fiscal 2026 it was $95.13M, up 59.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $95.13M | +59.0% |
| FY2025 | Apr 30, 2025 | $59.82M | +115.1% |
| FY2024 | Apr 30, 2024 | $27.81M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $30.97M | +59.9% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | $28.64M | +66.2% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | $24.55M | +62.7% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $22.57M | +53.4% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | $19.37M | +51.5% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $17.23M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | $15.09M | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | $14.71M | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | $12.78M | – |
See a number that looks wrong?